[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-350970-105":59,"doc-detail-350970-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","sirt7-as-a-context-dependent-biomarker-and-therapeutic-target-insights-from-a-pan-cancer-study","SIRT7 as a context-dependent biomarker and therapeutic target: Insights from a pan-cancer study","","SIRT7, a sirtuin family member, plays complex cancer roles with both tumor-promoting and tumor-suppressing effects. Although its connection to NAD+ metabolism and transcriptional regulation is well recognized, a systematic pan-cancer evaluation of its prognostic value, mutational effects, immune associations, and therapeutic potential has remained limited. An integrated computational workflow was used to assess structure, interactions, hallmark links, expression, survival, mutations, immune infiltration, and structure-based drug discovery. Deep neural network analyses positioned SIRT7 as a central hub linking NAD+ metabolism and transcriptional regulation. Differential expression across 17 cancer types showed poor survival links in six cancers and better outcomes in sarcoma, while cancer-specific mutations altered network component expression and survival. Regulatory mechanisms involved five miRNAs and three transcription factors, and two SIRT7 inhibitors were identified with stronger binding than a reference inhibitor.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/sirt7-as-a-context-dependent-biomarker-and-therapeutic-target-insights-from-a-pan-cancer-study/350970/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/sirt7-as-a-context-dependent-biomarker-and-therapeutic-target-insights-from-a-pan-cancer-study/350970.png","ImageObject",300,407,{"name":92,"@type":93},"Hazel","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the study’s main goal regarding SIRT7?","Question",{"text":112,"@type":113},"To evaluate the pan-cancer significance of SIRT7 by integrating computational analyses aimed at clarifying its prognostic value, mutational impact, immune associations, and therapeutic potential.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What methods were used to analyze SIRT7 across cancers?",{"text":117,"@type":113},"The study combined protein structure modeling, deep neural network-guided interaction analysis, cancer hallmark association, gene expression profiling, survival and mutation analyses, immune infiltration assessment, and structure-based drug discovery using molecular docking and dynamics simulations.",{"name":119,"@type":110,"acceptedAnswer":120},"How did SIRT7 expression relate to patient survival across cancer types?",{"text":121,"@type":113},"SIRT7 expression differed across 17 cancer types; high expression was linked to poor survival in six cancers, but correlated with better outcomes in sarcoma.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},350970,1790170593,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},137441390410,"https://ap-avatar.wpscdn.com/avatar/2000252f4ab5702993?_k=1776741390130283984","OPEN ACCESS  \nCitation: Islam KMT, Mahmud S (2026) SIRT7 as a context-dependent biomarker and therapeutic target: Insights from a pan-cancer study. PLoS One 21(2): e0342269. [https://doi](https://doi). org/10.1371/journal.pone.0342269  \nEditor: Firoz Ahmed, Hamad Medical Corporation, QATAR  \nReceived: August 11, 2025  \nAccepted: January 20, 2026  \nPublished: February 5, 2026  \nPeer Review History: PLOS recognizes the benefits of transparency in the peer review process; therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. The editorial history of this article is available here: [https://doi.org/10.1371/journal](https://doi.org/10.1371/journal). pone.0342269  \nCopyright: © 2026 Islam, Mahmud. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.  \nRESEARCH ARTICLE  \nSIRT7 as a context-dependent biomarker and therapeutic target: Insights from a pan-cancer study  \nK.M. Tanjida Islam‡, Shahin Mahmud‡*  \nDepartment of Biotechnology and Genetic Engineering, Mawlana Bhashani Science and Technology University, Tangail, Bangladesh  \n‡ KMTI and SM equally contributed as first author on this work.  \n* [shahin018mbstu@gmail.com](shahin018mbstu@gmail.com), [shahinbge@mbstu.ac.bd](shahinbge@mbstu.ac.bd)  \nAbstract  \nSIRT7 is a member of the sirtuin family and has emerged as a crucial player in cancer biology, with a multifaceted role in both tumor-promoting and tumorsuppressing activities. Despite its importance in connecting NAD+ metabolism with transcriptional regulation, a systematic analysis across multiple cancer types remains underexplored, thereby limiting our understanding of its prognostic value, mutational impact, immune associations, and therapeutic potential. Therefore, this study aims to evaluate the pan-cancer significance of SIRT7 through integrated computational approaches. We employed protein structure modeling, deep neural network-guided protein interaction analysis, cancer hallmark association, gene expression profiling, survival analysis, mutational landscape, immune infiltration assessment, and structure  \nbased drug discovery, combining molecular docking and dynamics simulations. Our deep neural network analyses revealed SIRT7 as a central hub connecting NAD+ metabolism with transcriptional regulation in its sub-network (R2 : 0.9839) . SIRT7 exhibited differential expression across 17 cancer types, with high expression associated with poor survival in six cancer types; however, it surprisingly correlated with better outcomes in sarcoma. Cancer-specific mutations significantly reduced patient survival and altered the expression of network components. We identified regulatory mechanisms involving five miRNAs and three transcription factors. Therapeutic intervention identified two promising SIRT7 inhibitors (ZINC000150487575 and ZINC000150641215) with superior binding properties compared to the reference inhibitor. This comprehensive pan-cancer analysis of SIRT7 provides a framework for understanding its role in cancer biology and identifies potential therapeutic opportunities for personalized interventions. Our findings have immediate implications for clinical oncology, enabling SIRT7 as a biomarker for patient stratification and a therapeutic target for novel inhibitor development. Targeting SIRT7 may offer new therapeutic strategies for various cancers, particularly those with high SIRT7  \nPLOS One | [https://doi.org/10.1371/journal.pone.0342269](https://doi.org/10.1371/journal.pone.0342269) February 5, 2026 1 / 35  \nData availability statement: All relevant data are within the manuscript and its Supporting  Information files.  \nFunding: The author(s) received no specific funding for this work.  \nCompeting interests: The authors have declared that no competing int","cbCainKewsE6wev4","https://ap.wps.com/l/cbCainKewsE6wev4","pdf",3756967,35,"English","# Introduction\n## Global cancer burden and molecular alterations\n## SIRT7 functions in cancer\n## Roles in metabolism and genomic stability","[{\"question\":\"What is the study’s main goal regarding SIRT7?\",\"answer\":\"To evaluate the pan-cancer significance of SIRT7 by integrating computational analyses aimed at clarifying its prognostic value, mutational impact, immune associations, and therapeutic potential.\"},{\"question\":\"What methods were used to analyze SIRT7 across cancers?\",\"answer\":\"The study combined protein structure modeling, deep neural network-guided interaction analysis, cancer hallmark association, gene expression profiling, survival and mutation analyses, immune infiltration assessment, and structure-based drug discovery using molecular docking and dynamics simulations.\"},{\"question\":\"How did SIRT7 expression relate to patient survival across cancer types?\",\"answer\":\"SIRT7 expression differed across 17 cancer types; high expression was linked to poor survival in six cancers, but correlated with better outcomes in sarcoma.\"}]","SIRT7 as a context-dependent biomarker and therapeutic target: Insights from a pan-cancer study | PDF",1790092114,88,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/76937ad37a803d0f600fb774568d32b7.webp",983,1272,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7fcd35140bb5b89907dcc059fa4bfb31.webp",982,1270,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ec2babc1fe99be98f776e1b58f93c204.webp",981,1269,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2cb60fe0e37ac001b3a53391c1f6bac4.webp",980,1268]